Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
02/2006
02/22/2006EP1626694A2 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry
02/22/2006EP1402005A4 A method of purification of cells
02/22/2006EP1320300B1 Food supplement
02/22/2006EP1244803B1 Veto cells effective in preventing graft rejection and devoid of graft versus host potential
02/22/2006EP1109564B1 Method for removal of hiv and other viruses from blood
02/22/2006EP1040185B1 Neural precursor cells, method for the production and use thereof in neural defect therapy
02/22/2006EP0729297B1 Hepatoblasts and method of isolating same
02/22/2006CN1738630A Cholesterol-lowering preparation, food supplement and foodstuff, and methods for preparing same
02/22/2006CN1738624A Method of treatment of myocardial infarction
02/22/2006CN1738595A Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters
02/22/2006CN1737113A Novel bacillus named BARB and its uses
02/22/2006CN1737103A Propolis wine
02/22/2006CN1736451A Externally applied plaster for stopping muscles and bones pain
02/22/2006CN1736394A An anti-AIDS injection and preparation process thereof
02/22/2006CN1736393A An anit-AIDS material drug, formulation and preparation process thereof
02/22/2006CN1736261A Alcohol-dissolving liver-protecting healthy food
02/22/2006CN1243088C Healthy bee glue soaps
02/22/2006CN1243020C Application of cardiokinetic hormone in liver disease
02/22/2006CN1242806C Chinese medicinal preparation for treating alphos and ichthyosys
02/22/2006CN1242803C Small honey pills for treating thrombus disease and its preparing process
02/22/2006CN1242799C Medicine for treating pointed condyloma with pure Chinese medicine
02/22/2006CN1242798C Externally used Chinese traditional medicine for relieving cough
02/22/2006CN1242794C Chinese traditional medicine preparation for treating leucemia and solid tumor
02/22/2006CN1242792C Chinese medicinal composition for promoting the production of body liquid and resisting diarrhoea
02/22/2006CN1242788C Chinese medicine for curing diarrhea and its preparation method
02/22/2006CN1242785C Medication for treating ulcer of oral cavity and preparation method
02/22/2006CN1242784C Xiangbei notoginseng powder for treating gastric ulcer
02/22/2006CN1242783C Medicine for treating acute pharyngitis and acute tonsillitis and its preparing method
02/22/2006CN1242781C Medicine for treating urticaria
02/22/2006CN1242780C Medicine composition for antagonizing poison-side effect caused by psychotropic drug
02/22/2006CN1242779C Liver disease treating Chinese medicine
02/22/2006CN1242778C Medicine for treating cardiovascular and cerebrovascular disease and hemiparalysis
02/22/2006CN1242777C Muscle and bone pain plaster and its making method
02/22/2006CN1242776C Worm nutritious health oral liquid and its preparing method
02/22/2006CN1242775C Process for preparing dropsy-treating powder
02/22/2006CN1242774C Medicine for treating proliferation arthritis of spine and its preparation method
02/22/2006CN1242773C Medicine for treating skin wound and its processing method
02/22/2006CN1242769C Preparation capable of promoting growth and intelligence development for teenagers and children as well as its preparing method
02/22/2006CN1242768C Hepatitis treating medicine and its preparing process
02/22/2006CN1242766C Medicine for preventing and treating chronic exhaustion syndrome and preparing method thereof
02/22/2006CN1242761C Numbness-activating blood-circulation-promoting pain-relieving ointment
02/22/2006CN1242760C Powder preparation for treating burn and skin trauma
02/22/2006CN1242758C Filmy lagging cover tablet for treating cold
02/22/2006CN1242756C Chinese medicine for trauma and preparation method
02/22/2006CN1242753C Cauma therapeutic liquid
02/22/2006CN1242750C Biodegradable and biocompatible polymeric microsphores encapsulating salmonella enteritidis bacteria
02/22/2006CN1242741C Preparation and diabetic use of gibberellins
02/22/2006CN1242739C Biological skin protective film
02/21/2006US7001993 site-directed mutagenesis; high protease-inhibitory activity in absence of heparin
02/21/2006US7001885 Isolation of biopolymers from human serum albumin; obtain human serum albumin, expose to ion exchange resin, elute and recover biopolymer
02/21/2006US7001764 Compositions comprising tissue specific adenoviral vectors
02/21/2006US7001760 Hepatitis B virus vectors for gene therapy
02/21/2006US7001756 and hypercholesterolemia, atherosclerosis and coronary heart disease; dosage forms; use with Auricularia polytricha (wood ear), an edible fungi
02/21/2006US7001715 Hemoglobulin blood substitute
02/21/2006US7001621 Blends of ursolic acid/oleanolic acid
02/21/2006US7001619 Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs
02/21/2006US7001602 Administering a neurotoxin ; therapy for enlargement of prostate gland
02/21/2006US7001596 vector comprises tumor specific promoter, for killing neoplastic cells
02/21/2006US7001430 Matrix composition for human grafts/implants
02/21/2006US7001321 Carrier for holding a flexible fluid processing container
02/16/2006WO2006017627A2 Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance
02/16/2006WO2006017417A2 Compositions and methods for the enhancement of chemotherapy with microbial cytotoxins
02/16/2006WO2006017374A2 Nutritional supplement composition and method
02/16/2006WO2006016247A2 Lysis/resealing process and device for incorporating an active ingredient in erythrocytes
02/16/2006WO2005048957A3 Novel insertion sites in pox vectors
02/16/2006WO2005020916A3 Myoblast treatment of diseased or weakened organs
02/16/2006US20060036331 Polymer-ceramic-hydrogel composite scaffold for osteochondral repair
02/16/2006US20060035857 Methods and compositions for the diagnosis and treatment of cancer
02/16/2006US20060035809 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
02/16/2006US20060035328 Artery-and vein-specific proteins and uses therefor
02/16/2006US20060034950 Slows down the atherosclerolic changes, delaying the onset of hypertension delays the development of frank diabetes mellitus and also slows down the early cognitive decline
02/16/2006US20060034938 Therapeutic mixture comprising antisense agents, chemotherapeutic compounds and bile extract for use in treatment of cell proliferative disorders
02/16/2006US20060034881 Animal bone fiber and method of producing the same
02/16/2006US20060034863 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof
02/16/2006US20060034817 Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase
02/16/2006US20060034814 Probiotic bacteria
02/16/2006US20060034811 Melanoma vaccine and methods of making and using same
02/16/2006US20060034809 comprising freeze-dried platelets, microparticles, or both for use as a hemostat; for treating bleeding or injuries associated with bleeding such as hemophilia, side-effect of an anti-cancer treatment, wound or trauma, bleeding disorder, surgery
02/16/2006US20060034807 Innervated artificial tissues and uses thereof
02/16/2006US20060034802 Procedure for the large-scale t-lymphocytes culture in a homogeneous system
02/16/2006US20060034783 disinfectant containing ferric ions (Fe+3) and L-ascorbic acid as the principal components and one or more of sorbic acid, benzoic acid and para-hydroxybenzoic acid esters, and then injecting a preparation containing a Lactobacillus casei into the affected part
02/16/2006US20060034767 Targeting and tracking of cells to specific organs and tissues in vivo
02/16/2006CA2575617A1 Lysis/resealing process and device for incorporating an active ingredient in erythrocytes
02/15/2006EP1626096A2 In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1)
02/15/2006EP1626056A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
02/15/2006EP1625861A1 Container for serum production and method of regenerative medicine using the same
02/15/2006EP1625852A1 Chimeric flavivirus vaccines
02/15/2006EP1625832A1 Method of removing cell
02/15/2006EP1625336A2 Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
02/15/2006EP1625335A2 Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
02/15/2006EP1625334A2 Percussively ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
02/15/2006EP1625213A2 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system
02/15/2006EP1624883A2 Compositions and methods related to production of erythropoietin
02/15/2006EP1624762A1 A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal binding property, an infection protection property and a fiber fermenting property
02/15/2006EP1624758A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
02/15/2006EP1624752A2 Delivery of compounds with rehydrated blood cells
02/15/2006EP1624751A2 Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
02/15/2006EP1482787A4 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
02/15/2006EP0871738B1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications
02/15/2006EP0795021B1 Retroviral delivery of full length factor viii